15.11.2022 Artax Biopharma Expands Company’s Scientific Advisory Board

Press Release
10.11.2022Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights

Press Release
10.11.2022Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage Choroidal Melanoma

Press Release
07.11.2022Aleta Biotherapeutics Receives Innovation Passport Designation for Biologic CAR T-Cell Therapy Engager ALETA-001

Press Release
19.10.2022PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer

Press Release
03.10.2022Aura Biosciences Announces Interim Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma Presented at AAO 2022

Press Release
28.09.2022Aura Biosciences Announces First Patient Dosed in Phase 1 Study Evaluating Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

Press Release
12.09.2022AviadoBio selected by Fierce Biotech as a ‘Fierce 15’ 2022 winner

Press Release
12.09.2022Fierce Biotech Names Amphista Therapeutics as One of its “Fierce 15” Biotech Companies of 2022

Press Release
04.08.2022F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

Press Release